Sanguine Biosciences

Overview

Sanguine Biosciences is a United States-based company founded in 2010, specializing in the collection and analysis of human biospecimens to support drug and diagnostics development. Operating within the Business Services industry, particularly in Research & Development and Biotech, Sanguine addresses the challenges of translating laboratory research into real-world medical applications. The company emphasizes the importance of integrating biospecimens with comprehensive patient data, including medical records and patient-reported outcomes, to enhance the utility of biomarkers in precision medicine. Sanguine's capabilities include a biorepository that offers custom services for biospecimen processing, storage, and delivery, which aim to streamline research efforts and reduce variability in results. The company has developed a direct-to-patient approach, engaging a community of over 70,000 patients to facilitate participation in therapeutic research, thereby providing researchers with access to relevant patient data and biospecimens essential for advancing medical research initiatives.

Industry